Axsome Therapeutics (AXSM) Reports Q4 Loss Per Share of $0.12

Axsome Therapeutics (NASDAQ: AXSM) reported Q4 EPS of ($0.12), versus ($0.14) reported last year.

For earnings history and earnings-related data on Axsome Therapeutics (AXSM) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
• Bernstein SocGen on Darden Restaurants (DRI): 'Story Intact'